Zivo Bioscience Inc (ZIVO) — Financial Flexibility Index
Zivo Bioscience Inc (ZIVO) has a Financial Flexibility Index of -0.05x as of March 2026. Free cash flow of $-210.70K (operating CF $-210.70K minus capex $4.00) represents 0% of total liabilities ($3.94 Million). Check Zivo Bioscience Inc (ZIVO) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zivo Bioscience Inc Financial Flexibility Index (2003–2025)
Historical Financial Flexibility Index trend for Zivo Bioscience Inc across 23 annual periods. For the full cash flow conversion analysis, see ZIVO cash generation efficiency.
Annual Financial Flexibility Index for Zivo Bioscience Inc (2003–2025)
Year-by-year free cash flow to debt coverage for Zivo Bioscience Inc. Explore Zivo Bioscience Inc (ZIVO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.75x | $-3.29 Million | $-3.29 Million | $4.41 Million | ▲ +62.7% |
| 2024 | -2.00x | $-4.31 Million | $-4.31 Million | $2.16 Million | ▲ +4.8% |
| 2023 | -2.10x | $-5.80 Million | $-5.80 Million | $2.76 Million | ▲ +36.9% |
| 2022 | -3.33x | $-7.10 Million | $-7.10 Million | $2.13 Million | ▼ -44.2% |
| 2021 | -2.31x | $-6.80 Million | $-6.80 Million | $2.95 Million | ▼ -928.1% |
| 2020 | -0.22x | $-2.59 Million | $-2.59 Million | $11.53 Million | ▲ +47.3% |
| 2019 | -0.43x | $-3.71 Million | $-3.71 Million | $8.71 Million | ▼ -93.0% |
| 2018 | -0.22x | $-5.01 Million | $-5.01 Million | $22.69 Million | ▼ -6.7% |
| 2017 | -0.21x | $-4.24 Million | $-4.24 Million | $20.51 Million | ▼ -16.8% |
| 2016 | -0.18x | $-2.54 Million | $-2.54 Million | $14.36 Million | ▲ +26.2% |
| 2015 | -0.24x | $-2.30 Million | $-2.30 Million | $9.57 Million | ▲ +43.2% |
| 2014 | -0.42x | $-2.74 Million | $-2.74 Million | $6.47 Million | ▼ -87.4% |
| 2013 | -0.23x | $-2.65 Million | $-2.99 Million | $11.77 Million | ▲ +46.6% |
| 2012 | -0.42x | $-1.77 Million | $-1.77 Million | $4.19 Million | ▲ +18.3% |
| 2011 | -0.52x | $-1.29 Million | $-1.29 Million | $2.49 Million | ▲ +52.7% |
| 2010 | -1.09x | $-1.41 Million | $-1.44 Million | $1.29 Million | ▼ -302.5% |
| 2009 | -0.27x | $-1.14 Million | $-1.15 Million | $4.19 Million | ▲ +68.3% |
| 2008 | -0.85x | $-816.07K | $-935.82K | $954.74K | ▲ +37.2% |
| 2007 | -1.36x | $-1.40 Million | $-1.41 Million | $1.03 Million | ▲ +20.0% |
| 2006 | -1.70x | $-1.97 Million | $-2.09 Million | $1.15 Million | ▼ -30.4% |
| 2005 | -1.31x | $-1.63 Million | $-1.65 Million | $1.25 Million | ▼ -17.9% |
| 2004 | -1.11x | $-1.28 Million | $-1.28 Million | $1.16 Million | ▼ -191.6% |
| 2003 | -0.38x | $-17.39K | $-17.39K | $45.78K | — |